Recombinant MS4A1 (Obinutuzumab Biosimilar) 抗体
This anti-MS4A1 (Obinutuzumab Biosimilar) antibody is a 小鼠 单克隆 antibody detecting MS4A1 (Obinutuzumab Biosimilar) in FACS 和 in vivo. Suitable for 人.
Quick Overview for Recombinant MS4A1 (Obinutuzumab Biosimilar) 抗体 (ABIN7795118)
抗原
MS4A1 (Obinutuzumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
小鼠
克隆类型
单克隆
标记
This MS4A1 (Obinutuzumab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), In vivo Studies (in vivo)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Obinutuzumab Biosimilar, CD20 Monoclonal Antibody
-
产品特性
- Obinutuzumab Biosimilar uses the same protein sequences as the therapeutic antibody obinutuzumab. Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil. In contrast to rituximab, which is a classic type I CD20 antibody, obinutuzumab binds to type II CD20 antibodies. This allows obinutuzumab to have a much higher induction of antibody-dependant cytotoxicity and a higher direct cytotoxic effect than the classic CD20 antibodies.
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method
-
免疫原
- Human CD20
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- MS4A1 (Obinutuzumab Biosimilar)
-
别名
- Obinutuzumab Biosimilar
-
物质类
- Biosimilar
抗原
-
You are here:
